NYSE ARCA | ETF
The fund is an actively managed ETF that seeks to achieve its investment objective by investing, under normal circumstances, at least 80% of its net assets (plus any borrowings for investment purposes) in securities of companies that derive at least 50% of their net revenue from or devote 50% of their assets to psychedelic drugs and derivatives that have economic characteristics similar to such securities.
The fund primarily invests in publicly listed life sciences companies focused on psychedelic medicines as well as other companies with activities in the psychedelics business.
The fund is non-diversified.
Top 20 Holdings
| Asset | Name | Sector | Industry | Weight |
|---|---|---|---|---|
| MNMD | Mind Medicine Inc | Healthcare | Biotechnology | 8.14% |
| CYBN | Cybin Inc | Healthcare | Biotechnology | 7.94% |
| CYBN | Cybin Inc | Healthcare | Biotechnology | 7.55% |
| SAGE | Sage Therapeutic | Healthcare | Biotechnology | 7.48% |
| ATAI | ATAI Life Sciences BV | Healthcare | Biotechnology | 7.10% |
| NRXP | NRX Pharmaceuticals Inc | Healthcare | Biotechnology | 6.70% |
| ALKS | Alkermes Plc | Healthcare | Drug Manufacturers - Specialty & Generic | 6.48% |
| STIM | Neuronetics Inc | Healthcare | Diagnostics & Research | 6.32% |
| CMPS | Compass Pathways Plc | Healthcare | Medical Care Facilities | 6.24% |
| TTTXX | BlackRock Liquidity Funds - Treasury Trust Fund | 5.27% | ||
| QNTM | Quantum BioPharma Ltd Ordinary Shares - Class B (Sub Voting) | 5.20% | ||
| QNTM | Quantum BioPharma Ltd. | Healthcare | Drug Manufacturers - Specialty & Generic | 5.03% |
| ITCI | Intracellular Th | Healthcare | Drug Manufacturers - Specialty & Generic | 4.65% |
| NEUP | Neuphoria Therapeutics Inc | Healthcare | Biotechnology | 4.62% |
| GHRS | GH Research PLC | Healthcare | Biotechnology | 4.33% |
| NBIX | Neurocrine Biosciences Inc | Healthcare | Drug Manufacturers - Specialty & Generic | 4.32% |
| CMND | Clearmind Medicine Inc. Common Shares | Healthcare | Biotechnology | 2.79% |
| SLZA | ENVERIC BIOSCI.INC.DL-01 | Healthcare | Biotechnology | 1.97% |
| SILO | Silo Pharma Inc | Healthcare | Biotechnology | 1.71% |
| RLMD | Relmada Therapeutics Inc | Healthcare | Biotechnology | 1.07% |